Development Personnel Sample Clauses

Development Personnel. ImproveNet will dedicate, as mutually agreed upon by GEA and ImproveNet, sufficient personnel with appropriate risk management skill to the development and integration effort contemplated by this Agreement in order to ensure that the ImproveNet System is developed and integrated in accordance with the Schedule.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Development Personnel. As part of the Hosting Services, GT shall make available a sufficient number of experienced GT employees (the "GT Development Team") to implement the specifications, to launch, maintain and update the Sites, and to provide the development and implementation services covered by All Work Orders entered into by the parties. The GT Development Team shall supervise the technical planning, implementation and maintenance of the Sites and serve as liaison with AXP personnel, vendors and representatives who have responsibilities in connection with the Sites.
Sample 1Sample 2Sample 3
Development Personnel. Manager shall provide and make available qualified and competent professional, supervisory, managerial, administrative and other personnel as reasonably necessary to perform the Work in accordance with the terms of this Agreement.
Sample 1Sample 2
Development Personnel. Each Party will dedicate sufficient personnel with appropriate technical skills to the development effort to ensure that the Music Protection Technology is developed in accordance with the Specification. Without limiting the foregoing, TTR will assign the personnel resources set forth in Exhibit D. All engineers and other staff which may be assigned by TTR or Macrovision to develop the Music Protection Technology shall at all times be employees or consultants of TTR or Macrovision, respectively. Each Party may, at its option, employ the services of contractors or consultants to assist in the development of the Music Protection Technology. Such Party will be held fully responsible for and guarantee the work and activities of each of its subcontractors, including but not limited to each subcontractor's compliance with this Agreement.
Sample 1
Development Personnel. Except with respect to any work required to be performed by the City hereunder, Xxxxxxx shall provide all necessary personnel required to develop the Property in accordance with this Agreement. Xxxxxxx will cause its personnel, contractors and consultants to devote the time and effort necessary to satisfy its obligations hereunder.
Sample 1
Development Personnel. BuildNet will dedicate, as mutually agreed upon by the Technical Contacts, sufficient personnel with appropriate technical skill to the development and integration effort to ensure that the BuildNet System is developed and the integration completed in accordance with the Schedule.
Sample 1
Development Personnel. ISSC will be responsible for ensuring maximum productivity of the personnel assigned to AD/M Projects efforts, other than the Schedule N Projects set forth in Schedule N as of the Commencement Date, as described in the resource Baselines in the Supplement and Schedule J (the "Baseline Personnel"). Flagstar shall have the right to monitor the status of the AD/M Projects. ISSC shall provide Flagstar with monthly reports in appropriate detail as reasonably requested by Flagstar, specifying how ISSC used the Baseline Personnel during the relevant period, ISSC's plan for using such Baseline Personnel in the next period and the status of each approved AD/M Project service request (either pending or in progress), as well as the status of on-going AD/M Projects assigned thereto. The report shall also specify the extent to which the Baseline Personnel are available to perform any new work. ISSC shall provide further status information upon Flagstar's reasonable request. In addition, ISSC shall make appropriate Personnel available to meet with Flagstar on at least a monthly basis to review the status of existing AD/M Projects, to discuss new AD/M Projects, and to review the utilization of the Baseline Personnel. If AD/M Projects are behind schedule the Parties may agreed to a greater frequency of review.
Sample 1
AutoNDA by SimpleDocs
Development Personnel. All engineers and other staff which may be assigned by Ambient or Aquila to develop the Projects shall at all times be employees or consultants of Ambient or Aquila to develop the Projects shall at all times by employees or consultants of Ambient or Aquila, respectively. Each Party may, at its option and expense, employ the services of contractors or consultants to assist in the development of the Projects. Such Party will be held fully responsible for and guarantee the work and activities of each of its subcontractors.
Sample 1

Related to Development Personnel

  • Collaboration Management Promptly after the Effective Date, each Party will appoint a person who will oversee day-to-day contact between the Parties for all matters related to the management of the Collaboration Activities in between meetings of the JSC and will have such other responsibilities as the Parties may agree in writing after the Effective Date. One person will be designated by Merck (the “Merck Program Director”) and one person will be designated by Moderna (the “Moderna Program Director,”) together will be the “Program Directors”. Each Party may replace its Program Director at any time by notice in writing to the other Party. Any Program Director may designate a substitute to temporarily perform the functions of that Program Director by written notice to the other Party. The initial Program Directors will be: For Moderna: [***] For Merck: [***]

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones)

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Program Term The Research Program shall be conducted during the period of five years commencing as of the Agreement Date ("Research Program Term"). Upon not later than seventy-five (75) days' prior written notice JT may, in its sole judgment, terminate the Research Program at the end of the third (3/rd/) year and fourth (4/th/) year of the Research Program. The RMC may terminate the Research Program any time during the Research Program Term if it unanimously determines the Research Program is no longer scientifically useful or that all potential Products would not be commercially viable. In case of such an early termination by JT or the RMC, JT shall be exempt from any payment(s) under Section 10(a) that would have become due and payable after the effective date of such early termination. Following any termination of the Research Program (i) that occurs simultaneously with the termination of this Agreement in accordance with Section 13 (i.e., no compound or Lead Compound has been designated previously a Collaboration Lead Compound in accordance with Section 3(b) and no Independent Lead Compound is being developed in accordance with Section 3(m)) or (ii) that is followed at some future date by the termination by JT of Development or co-promotion of any Collaboration Lead Compound and/or Product pursuant to Sections 3(l) or 5(c), respectively, or development of an Independent Lead Compound in accordance with Section 3(m) (A) any licenses granted by Tularik to JT will terminate, (B) JT will grant to Tularik an exclusive, sublicensable, worldwide license, to make, use and sell compounds, Collaboration Lead Compounds or Products under JT's interest in Program Patents and Program Know-How and (C) under the terms and conditions to be separately agreed, JT will also grant to Tularik a nonexclusive, sublicensable, worldwide license under any JT Patent Rights and Know-How to the extent necessary to practice the license granted under the Program Patents and Program Know-How in (B) (including, with respect to compounds, a limited number of JT's library compounds approved by JT); provided, however, that in the event the Research Program terminates but the Agreement has not terminated with respect to designated Collaboration Lead Compounds, Independent Lead Compounds and/or Products as provided in Section 2(g)(ii), Sections 2(g)(A), (B) and (C) shall apply only to those compounds, Collaboration Lead Compounds, Independent Lead Compounds and Products for which Development or co-promotion shall have been terminated and/or to those compounds or Lead Compounds that have not been designated previously a Collaboration Lead Compound in accordance with Section 3(b) or an Independent Lead Compound in accordance with Section 3(m); provided further that in the event that JT elects to pursue a Discontinued Compound or a Non-Proposed Compound on or before the first anniversary of the expiration or termination of the Research Program Term pursuant to Section 3(b)(iii) or 3(b)(iv), respectively, Sections 2(g)(A), (B) and (C) shall not apply to such Discontinued Compound or Non-Proposed Compound until such time as JT shall have terminated the Development or co-promotion of such Discontinued Compound or Non- Proposed Compound. Tularik will then be free to pursue clinical development and registration of such compounds, Lead Compounds and/or Products without obligation to JT except as provided in Section 4(f) or Section 5(c), as appropriate.

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

Time is Money Join Law Insider Premium to draft better contracts faster.